HK1169336A1 - Materials and methods relating to glycosylation of a therapeutic polypeptide - Google Patents

Materials and methods relating to glycosylation of a therapeutic polypeptide

Info

Publication number
HK1169336A1
HK1169336A1 HK12110238.7A HK12110238A HK1169336A1 HK 1169336 A1 HK1169336 A1 HK 1169336A1 HK 12110238 A HK12110238 A HK 12110238A HK 1169336 A1 HK1169336 A1 HK 1169336A1
Authority
HK
Hong Kong
Prior art keywords
glycosylation
materials
therapeutic polypeptide
methods relating
relating
Prior art date
Application number
HK12110238.7A
Other languages
English (en)
Chinese (zh)
Inventor
Andrew Graham Watts
Amanda Barbara Mackenzie
Terrence Kantner
Original Assignee
Glythera Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glythera Ltd filed Critical Glythera Ltd
Publication of HK1169336A1 publication Critical patent/HK1169336A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549Sugars, nucleosides, nucleotides or nucleic acids
HK12110238.7A 2009-06-16 2012-10-17 Materials and methods relating to glycosylation of a therapeutic polypeptide HK1169336A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18743409P 2009-06-16 2009-06-16
PCT/GB2010/001188 WO2010146362A2 (en) 2009-06-16 2010-06-16 Materials and methods relating to glycosylation

Publications (1)

Publication Number Publication Date
HK1169336A1 true HK1169336A1 (en) 2013-02-22

Family

ID=43086298

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12110238.7A HK1169336A1 (en) 2009-06-16 2012-10-17 Materials and methods relating to glycosylation of a therapeutic polypeptide

Country Status (9)

Country Link
US (1) US9452223B2 (xx)
EP (1) EP2442831B9 (xx)
JP (2) JP6091892B2 (xx)
CN (1) CN102481377B (xx)
CA (1) CA2768155C (xx)
ES (1) ES2560557T3 (xx)
HK (1) HK1169336A1 (xx)
PL (1) PL2442831T3 (xx)
WO (1) WO2010146362A2 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010146362A2 (en) * 2009-06-16 2010-12-23 The University Of Bath Materials and methods relating to glycosylation
TW201442721A (zh) * 2013-01-23 2014-11-16 Daiichi Sankyo Co Ltd 糖鏈修飾心房利尿鈉肽
CN106415244B (zh) * 2014-03-27 2020-04-24 中央研究院 反应性标记化合物及其用途
RU2656140C2 (ru) * 2016-11-14 2018-05-31 Федеральное государственное бюджетное учреждение "Государственный научный центр Институт иммунологии" Федерального медико-биологического агентства России Способ получения гибридного белка, состоящего из рекомбинантного белка аналога интерферона гамма, конъюгированного с олигосахаридом

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69231127D1 (de) * 1991-03-18 2000-07-06 Scripps Research Inst La Jolla Oligosaccharide als enzymsubstrate und -inhibitoren: verfahren und zusammensetzungen
US5770407A (en) * 1996-12-10 1998-06-23 The Scripps Research Institute Process for preparing nucleotide inhibitors of glycosyltransferases
EP2292271A3 (en) 2001-10-10 2011-09-14 BioGeneriX AG Remodelling and glycoconjugation of an antibody
US7226903B2 (en) 2001-10-10 2007-06-05 Neose Technologies, Inc. Interferon beta: remodeling and glycoconjugation of interferon beta
WO2004035605A2 (en) * 2002-10-16 2004-04-29 The Scripps Research Institute Glycoprotein synthesis
BRPI0809670A8 (pt) 2007-04-03 2018-12-18 Biogenerix Ag métodos para aumentar a produção de célula tronco, para aumentar o número de granulócitos em um indivíduo, para prevenir, tratar e aliviar a mielossupressão que resulta de uma terapia contra o câncer, para tratar uma condição em um indivíduo, para tratar neutropenia e trombocitopenia em um mamífero, para expandir células tronco hematopoiéticas em cultura, para aumentar a hematopoiese em um indivíduo, para aumentar o número de célulars progenitoras hematopoiéticas em um indivíduo, e para fornecer enxerto estável da medula óssea, e, forma de dosagem oral.
AU2008323768A1 (en) 2007-11-09 2009-05-14 Baxter Healthcare S.A. Modified recombinant Factor VIII and von Willebrand Factor and methods of use
WO2010146362A2 (en) * 2009-06-16 2010-12-23 The University Of Bath Materials and methods relating to glycosylation

Also Published As

Publication number Publication date
JP2012530119A (ja) 2012-11-29
EP2442831B9 (en) 2016-05-11
WO2010146362A3 (en) 2011-06-30
US9452223B2 (en) 2016-09-27
PL2442831T3 (pl) 2016-06-30
US20120190631A1 (en) 2012-07-26
CN102481377B (zh) 2014-10-29
EP2442831A2 (en) 2012-04-25
CA2768155A1 (en) 2010-12-23
JP6091892B2 (ja) 2017-03-08
WO2010146362A2 (en) 2010-12-23
EP2442831B1 (en) 2015-11-04
JP2015187153A (ja) 2015-10-29
CA2768155C (en) 2016-08-23
CN102481377A (zh) 2012-05-30
ES2560557T3 (es) 2016-02-19

Similar Documents

Publication Publication Date Title
ZA201107702B (en) Composition and methods related to protein a(spa)variants
ZA201209561B (en) Compositions and methods related to protein a (spa) variants
IL252490A0 (en) Ceramic-ceramic bonding and related methods
ZA201200122B (en) Glucose-regulating polypeptides and methods of making and using same
IL215480A0 (en) Control of protein glycosylation and compositions and methods relating thereto
EP2547771A4 (en) PRODUCTION OF PROTEINS AND POLYPEPTIDES
HK1173654A1 (zh) 治療化合物及相關的使用方法
EP2440241A4 (en) GROWTH HORMONE POLYPEPTIDES AND METHODS OF MAKING AND USING THEM
IL216619A0 (en) Recombinant production of peptides
EP2495255A4 (en) GLYCOSYLATED FORM OF AN ANTIGENIC GLP-1 ANALOG
EP2655651A4 (en) A cost-effective method for expressing and purifying recombinant proteins in plants
IL215537A (en) Human recombinant alpha1-antitrapazine and a method for its production
IL216543A (en) Methods for enhancing production of human recombinant wild strain of beta-glucosidase
HK1169336A1 (en) Materials and methods relating to glycosylation of a therapeutic polypeptide
IL222714A0 (en) Preparation of polypeptides and salts thereof
ZA201209021B (en) Therapeutic peptide composition and method
HU0900706D0 (en) Preparation and application of hobby- creative auxiliary material
PL2411890T3 (pl) Interfejs dla systemu czujników planarnych i sposób sterowania nim
TWM365750U (en) Adhesive structure of breathable plaster
GB0906676D0 (en) Improvements in and relating to the consideration of evidence
GB0906275D0 (en) Improvements in and relating to the consideration of evidence